Supernus to Present at Jefferies Virtual Healthcare Conference
ROCKVILLE, Md., May 25, 2021 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and...
Day: May 25, 2021
Acer Therapeutics Plans NDA Submission for ACER-001 in Q3 2021 Following Pre-NDA Meeting with FDA
NEWTON, Mass. and GENEVA, Switzerland, May 25, 2021 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER)(“Acer”), a pharmaceutical company focused...
Chalice Brands Ltd. Reports Record First Quarter 2021 Revenues of $5.5 million and Consecutive Positive Adjusted EBITDA(1)
Focus on recapitalization, pipeline growth, and optimization of run stage in OregonPORTLAND, Ore., May 25, 2021 (GLOBE NEWSWIRE) -- Chalice...
Dimensions Health Centres Announces Closing of First Treatment Center on Maple Lake in the Algonquin Highlands
The 40-acre property is the first of several destination retreat centers integral to the Dimensions Health Centres treatment modelTORONTO, May...
MIMEDX Reminds Shareholders to Pre-Register for the Upcoming Virtual 2021 Annual Meeting of Shareholders
Deadline to Pre-Register Extended to May 26, 2021 at 10:00 a.m. Eastern Pre-Registration Required to Attend Annual Meeting Visit www.votemimedx.com...
Quotient Limited to Report Fiscal Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call
JERSEY, Channel Islands, May 25, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial...
PharmaTher Files for FDA Orphan Drug Designation for Ketamine to Treat Lou Gehrig’s Disease
TORONTO, May 25, 2021 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage...
Motus GI’s Pure-Vu System® Adopted by Sinai Hospital of Baltimore
Implementation of the Pure-Vu System is designed to improve efficiencies and outcomes of GI endoscopy proceduresFORT LAUDERDALE, Fla., May 25, 2021...
TRACON Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
SAN DIEGO, May 25, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the...
Avid Bioservices to Serve as Commercial Manufacturer for ADC Therapeutics’ ZYNLONTA™ (Loncastuximab Tesirine-Lpyl)
ZYNLONTA™ Recently Approved as First and Only CD19-Targeted Antibody Drug Conjugate for Single-Agent Treatment for Adult Patients with Relapsed or...
Immutep To Present At The Jefferies Virtual Healthcare Conference
SYDNEY, AUSTRALIA, May 25, 2021 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology...
Shape Therapeutics to Present the Discovery of Muscle-Specific AAVs at the Jefferies 2021 Virtual Healthcare Conference
SEATTLE, May 25, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene...
Inspire Medical Systems, Inc. to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference
MINNEAPOLIS, May 25, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on...
Connect Biopharma Announces First Subject Dosed in Phase I Trial Evaluating Safety, Tolerability and Pharmacokinetic Profile of CBP-174 in Healthy Adult Subjects
Development program exploring the potential of CBP-174 in the treatment of chronic inflammatory pruritus SAN DIEGO and TAICANG, SUZHOU, China,...
Alloy Therapeutics and Pyxis Oncology Form Kyma Therapeutics to Develop Novel Immune-Modulating Antibodies for Cancer and Autoimmune Diseases
LEXINGTON, Mass. and CAMBRIDGE, Mass., May 25, 2021 (GLOBE NEWSWIRE) -- Alloy Therapeutics (“Alloy”) and Pyxis Oncology ("Pyxis") today announced...
Enosi Life Sciences Featured on America’s Next Investment
Company’s appearance comes concurrently with its Regulation D, 506c OfferingEUGENE, Ore., May 25, 2021 (GLOBE NEWSWIRE) -- Enosi Life Sciences...
European Commission approves Venclyxto-based combinations for adults with newly diagnosed acute myeloid leukaemia who are ineligible for intensive chemotherapy
With hypomethylating agents significantly improved complete response rates in certain adults with newly diagnosed acute myeloid leukaemiaIn the VIALE-A study,...
Kronos Bio to Highlight Progress Across Pipeline and Outline Growth Strategy at Virtual R&D Day Today
Unveils development strategy for lanraplenib (LANRA), which will expand addressable patient population for SYK inhibitor portfolio in acute myeloid leukemia...
Avadel Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
DUBLIN, Ireland, May 25, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an...
NeuBase Therapeutics Appoints Dr. Kia Motesharei Chief Business and Strategy Officer
Expansion of management team continues with addition of an industry leader with deep experience in business development, licensing, and strategy...